BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35631344)

  • 1. Possible Association between the Use of Proton Pump Inhibitors and H
    Choi HG; Lee HK; Kang HS; Lim H; Kim JH; Kim JH; Kim NY; Cho SJ; Nam ES; Min KW; Kwon MJ
    Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
    Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
    J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Migraines and Prior Proton Pump Inhibitor Use: A Nested Case-Control Study Using a National Health Screening Cohort.
    Kang HS; Kim SY; Kim JH; Kim ES; Choi HG; Lim H; Kim JH; Park HY; Kim NY; Hong S; Choi KC; Kwon MJ
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36355557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
    Park JH; Song YM; Jung JH; Han K
    Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort.
    Choi HG; Kim JH; Kim JH; Kim ES; Park HY; Min KW; Kwon MJ
    Alzheimers Res Ther; 2022 Jul; 14(1):91. PubMed ID: 35773740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case-Control Study Using National Health Insurance Data.
    Kwon MJ; Han KM; Kim JH; Kim JH; Kim MJ; Kim NY; Choi HG; Kang HS
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study.
    Lin TK; Tsai CF; Huang JY; Pan LF; Jong GP
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.
    Huang CH; Tseng YH; Tsai WS; Su CC; Cheng CL; Kao Yang YH; Chang YC; Liu YH
    Infect Dis Ther; 2024 Feb; 13(2):373-383. PubMed ID: 38286955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea.
    Kwon MJ; Kang HS; Kim JH; Kim JH; Kim SH; Kim NY; Nam ES; Min KW; Choi HG
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
    Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
    BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter cohort analysis of fractures in histamine-2-receptor antagonist treated pediatric patients.
    Fleishman NR; Richardson T; Attard TM
    Curr Med Res Opin; 2022 Apr; 38(4):565-570. PubMed ID: 35112645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy.
    Rackoff A; Agrawal A; Hila A; Mainie I; Tutuian R; Castell DO
    Dis Esophagus; 2005; 18(6):370-3. PubMed ID: 16336606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.
    Fackler WK; Ours TM; Vaezi MF; Richter JE
    Gastroenterology; 2002 Mar; 122(3):625-32. PubMed ID: 11874994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Concomitant pH-Elevating Medications with Pazopanib on Progression-Free Survival and Overall Survival in Patients with Metastatic Renal Cell Carcinoma.
    McAlister RK; Aston J; Pollack M; Du L; Koyama T; Chism DD
    Oncologist; 2018 Jun; 23(6):686-692. PubMed ID: 29487220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.